BCL
PPH icon

Burnham & Co LLC’s VanEck Pharmaceutical ETF PPH Stock Holding History

Burnham & Co LLC’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.7K Buy
+400
New +$41.4K 0.04% 125

Other funds holding PPH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Burnham & Co LLC's PPH Position: Q2 2026 in Review

Burnham & Co LLC opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 400 shares worth $43.7K. The stake represents 0.04% of the portfolio and ranks #125 among its holdings.

117 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Burnham & Co LLC held 400 shares of VanEck Pharmaceutical ETF worth $43.7K as of Q2 2026.
  • VanEck Pharmaceutical ETF was a new Burnham & Co LLC position in Q2 2026.
  • VanEck Pharmaceutical ETF made up 0.04% of Burnham & Co LLC's portfolio in Q2 2026, its #125 holding.
  • 117 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Burnham & Co LLC's 13F filing for Q2 2026, filed 11 Aug 2026.